Effect of Mango on Gut Microbiota and Metabolic Health

Sponsor
Laval University (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT03825276
Collaborator
(none)
35
1
1
46.5
0.8

Study Details

Study Description

Brief Summary

Mango is rich in bioactive compounds such as dietary polyphenols and carotenoids, which may explain its beneficial effect on health. Polyphenols accumulate in the gut where they can positively modulate the microbiota. As gut microbiota may have a strong influence on cardiometabolic health, we hypothesize that mango consumption improves metabolic profile in overweight or obese individuals through beneficial changes in gut microbiota. The study of metagenomics, transcriptomics and metabolomics will be used to validate this hypothesis.

Condition or Disease Intervention/Treatment Phase
  • Dietary Supplement: Mango consumption
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
35 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Prevention
Official Title:
Metabolic Adaptations and Role of Nutritionally-Mediated Gut Microbiota Changes Following Mango Consumption in Overweight Men and Women : The MANGO Pilot Study
Actual Study Start Date :
Jan 15, 2019
Actual Primary Completion Date :
Dec 20, 2019
Anticipated Study Completion Date :
Dec 1, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: Mango consumption

Dietary Supplement: Mango consumption
Daily consumption of 280 g of frozen mangos during 8 weeks. The daily dose in equivalent to a 2-cups serving.

Outcome Measures

Primary Outcome Measures

  1. Changes in plasma insulin concentration of overweight/obese men and women taking frozen mangos daily [8 weeks]

  2. Changes in plasma glucose concentration of overweight/obese men and women taking frozen mangos daily [8 weeks]

  3. Changes in plasma triglycerides concentration of overweight/obese men and women taking frozen mangos daily [8 weeks]

  4. Changes in plasma total cholesterol concentration of overweight/obese men and women taking frozen mangos daily [8 weeks]

  5. Changes in plasma HDL cholesterol concentration of overweight/obese men and women taking frozen mangos daily [8 weeks]

  6. Changes in plasma LDL cholesterol concentration of overweight/obese men and women taking frozen mangos daily [8 weeks]

Secondary Outcome Measures

  1. Changes in waist circumference of overweight/obese men and women taking frozen mangos daily [8 weeks]

  2. Changes in hip circumference of overweight/obese men and women taking frozen mangos daily [8 weeks]

  3. Changes in waist to hip circumference ratio of overweight/obese men and women taking frozen mangos daily [8 weeks]

    Waist and hip circumference will be combined to report waist to hip ratio

  4. Height of overweight/obese men and women taking frozen mangos daily [Baseline]

  5. Changes in weight of overweight/obese men and women taking frozen mangos daily [8 weeks]

  6. Changes in body mass index (BMI) of overweight/obese men and women taking frozen mangos daily [8 weeks]

    Weight and height will be combined to report BMI

  7. Changes in systolic blood pressure of overweight/obese men and women taking frozen mangos daily [8 weeks]

  8. Changes in diastolic blood pressure of overweight/obese men and women taking frozen mangos daily [8 weeks]

  9. Changes in insulin secretion of overweight/obese men and women taking frozen mangos daily [8 weeks]

  10. Changes in insulin sensitivity of overweight/obese men and women taking frozen mangos daily [8 weeks]

  11. Changes in glycated hemoglobin (HbA1c) in overweight/obese men and women taking frozen mangos daily [8 weeks]

  12. Changes in plasma tumor necrosis factor (TNF-alpha) concentration of overweight/obese men and women taking frozen mangos daily [8 weeks]

  13. Changes in plasma interleukin-6 (IL-6) concentration of overweight/obese men and women taking frozen mangos daily [8 weeks]

  14. Changes in plasma high-sensitivity C-reactive protein (hs-CRP) concentration of overweight/obese men and women taking frozen mangos daily [8 weeks]

  15. Changes in gene expression in peripheral blood mononuclear cells (PBMC) of overweight/obese men and women taking frozen mangos daily [8 weeks]

    Gene-level expression from >20,000 annotated genes will be examined

  16. Changes in plasma metabolites concentration in overweight/obese men and women taking frozen mangos daily [8 weeks]

    Metabolites include acylcarnitines, glycerophospholipids, sphingolipids, sugars, amino acids, biogenic amines

  17. Changes in gut microbiota composition in overweight/obese men and women taking frozen mangos daily [8 weeks]

    Stool samples will be collected and whole metagenome shotgun sequencing analysis will be conducted

  18. Changes in plasma lipopolysaccharide (LPS) concentration of overweight/obese men and women taking frozen mangos daily [8 weeks]

  19. Changes in plasma LPS binding protein (LBP) concentration of overweight/obese men and women taking frozen mangos daily [8 weeks]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 55 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Healthy men and premenopausal women

  • At least one of the following : BMI between 25 and 40 kg/m2 or Waist circumference ≥ 80 cm for women and ≥ 94 cm for men

  • At least one of the following : TG ≥ 1.35 mmol/L or fasting insulinemia ≥ 42 pmol/L

  • Caucasian origin

Exclusion Criteria:
  • Nicotine use

  • Metabolic disorders or use of medication that may affect parameters measured in the study

  • Use of dietary supplements or natural health product that may affect parameters measured in the study

  • Use of antibiotics in the last 3 months

  • Surgery in the last 3 months or planned during the study timeline

  • Alcohol consumption >2 drinks/day

  • Weight change >5% in the last 3 months

  • Mango aversion, allergy or intolerance

  • Dietary restrictions (vegetarian, gluten avoidance...)

  • Berries consumption >1 serving/day

  • Pregnancy, breastfeeding or pregnancy planned within 3-6 months

Contacts and Locations

Locations

Site City State Country Postal Code
1 Laval University Québec Canada G1V 0A6

Sponsors and Collaborators

  • Laval University

Investigators

  • Principal Investigator: Charles.Couillard@fsaa.ulaval.ca Couillard, PhD, Laval University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Charles Couillard, Professor, Laval University
ClinicalTrials.gov Identifier:
NCT03825276
Other Study ID Numbers:
  • MANGO 2018-147
First Posted:
Jan 31, 2019
Last Update Posted:
Jul 7, 2021
Last Verified:
Jul 1, 2021
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Charles Couillard, Professor, Laval University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 7, 2021